Status:
COMPLETED
Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Epileptic Seizures
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Epilepsy is a common disease affecting 0.5 to 1% of the general population. Epilepsies refractory to drug treatment lead to increased morbidity, mortality and high costs for public health (representin...
Eligibility Criteria
Inclusion
- Patient presenting a drug-resistant partial epilepsy for which an indication is indicated after préchirugical balance assessment.
- Patient not presenting a psychiatric disease chronicles, an demential syndrome,
- Patient not presenting contraindication to the realization of an examination by MRI
Exclusion
- Patient suffering a not operable shape of partial epilepsy or a generalized epilepsy
- Patient suffering an evolutionary associated serious illness (cancer, autoimmune disease, hepatic insufficiency)
Key Trial Info
Start Date :
March 6 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2019
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT02304029
Start Date
March 6 2015
End Date
November 15 2019
Last Update
October 28 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique - Hopitaux de Marseille
Marseille, France, 13005
2
CHU Montpellier
Montpellier, France
3
CHU NICE
Nice, France
4
CHU Nimes
Nîmes, France